iShares Biotechnology ETF (IBB)

iShares Biotechnology ETF (IBB $163.78)
- $163.78 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $477.73)
- $477.73 P/E (TTM): 61.34X Cap: $169.65B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $451.59)
- $451.59 P/E (TTM): 30.25X Cap: $114.71B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $208.34)
- $208.34 P/E (TTM): 93.12X Cap: $368.38B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $237.28)
- $237.28 P/E (TTM): 21.59X Cap: $571.51B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $918.05)
- $918.05 P/E (TTM): 40.54X Cap: $867.39B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $114.50)
- $114.50 P/E (TTM): 15.92X Cap: $283.08B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $163.78)
- $163.78 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $577.12)
- $577.12 P/E (TTM): 44.88X Cap: $45.89B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $63.65)
- $63.65 P/E (TTM): 25.74X Cap: $7.51B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $92.24)
- $92.24 P/E (TTM): 14.7X Cap: $18.35B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $28.66)
- $28.66 P/E (TTM): 380.0X Cap: $245.38B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

iShares Biotechnology ETF (IBB $163.78)
- $163.78 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $121.11)
- $121.11 P/E (TTM): 17.2X Cap: $7.24B
- View XBI Profile
- View Questions on XBI
Natera Inc. (NTRA $197.79)
- $197.79 Cap: $28.03B
- View NTRA Profile
- View Questions on NTRA
ARK Genomic Revolution ETF (ARKG $26.34)
- $26.34 P/E (TTM): 27.48X Cap: $1.29B
- View ARKG Profile
- View Questions on ARKG
Catalyst Pharmaceuticals Inc. (CPRX $22.81)
- $22.81 P/E (TTM): 13.8X Cap: $2.78B
- View CPRX Profile
- View Questions on CPRX

Q: It looks like biotech stocks are on a tear, especially those that may benefit from AI. Do you have any names that you might recommend? I'm considering the Arkg fund but I don't quite trust Cathy Woods after losing money on the Arkk fund in 2021. Thank you,

Jason

Read Answer Asked by Jason on February 18, 2025

Biogen Inc. (BIIB $182.31)
- $182.31 P/E (TTM): 21.03X Cap: $26.75B
- View BIIB Profile
- View Questions on BIIB
Gilead Sciences Inc. (GILD $141.29)
- $141.29 P/E (TTM): 21.33X Cap: $175.40B
- View GILD Profile
- View Questions on GILD
Illumina Inc. (ILMN $122.95)
- $122.95 P/E (TTM): 22.09X Cap: $18.79B
- View ILMN Profile
- View Questions on ILMN
AbbVie Inc. (ABBV $208.34)
- $208.34 P/E (TTM): 93.12X Cap: $368.38B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $108.49)
- $108.49 P/E (TTM): 29.76X Cap: $188.95B
- View ABT Profile
- View Questions on ABT
Eli Lilly and Company (LLY $918.05)
- $918.05 P/E (TTM): 40.54X Cap: $867.39B
- View LLY Profile
- View Questions on LLY
Novo Nordisk A/S (NVO $37.45)
- $37.45 P/E (TTM): 10.8X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $163.78)
- $163.78 P/E (TTM): 20.63X Cap: $7.90B
- View IBB Profile
- View Questions on IBB
State Street SPDR S&P Biotech ETF (XBI $121.11)
- $121.11 P/E (TTM): 17.2X Cap: $7.24B
- View XBI Profile
- View Questions on XBI
First Trust NYSE Arca Biotechnology ETF (FBT $33.79)
- $33.79 P/E (TTM): 27.89X Cap: $3M
- View FBT Profile
- View Questions on FBT

Q: Hi 5i, can you give me the names of 4 or 5 large cap pharmaceutical companies that are buyable now. Also I'm looking for 4 or 5 Biotech companies with one drug in the market making money and maybe something in the pipeline that looks like it has a good future? for example TGTX.

Read Answer Asked by Mark on January 09, 2025